Archive — US — techcrunch
Sword Health nabs $40M at $4B valuation, pushes IPO plans to at least 2028
Sword Health has raised $40M in funding at a $4B valuation, a 33% increase from last year. Despite its strong performance and positive cash flow, CEO Virgílio Bento has postponed IPO plans to 2028, opting to enhance the company's valuation and expand its services. The startup aims to extend its AI healthcare solutions to various conditions while considering further funding next year.
Key points
- Sword Health raised $40 million at a $4 billion valuation, a 33% increase from last year.
- The funding round was led by General Catalyst and includes other investors like Khosla Ventures and Comcast Ventures.
- CEO Virgílio Bento sees the need for additional capital to update valuation and prepare for strategic acquisitions.
- Sword Health plans to expand its AI care services beyond musculoskeletal and pelvic health to areas like cardiovascular and speech therapy.
- Despite strong revenues and successful IPOs by competitors, Bento has delayed IPO expectations to 2028.
- Bento is focusing on learning from other public company CEOs to prepare for a potential future IPO.
Why it matters
- The health tech industry has experienced growth with IPOs from companies like Hinge Health and Omada.
- In 2025, there is an increasing trend towards AI integration within healthcare, influencing business strategies.
- Bento's approach reinforces the notion that strong private companies can sustain growth without immediate IPOs, echoing larger trends in the tech space.
Sword Health's strategic decision to delay its IPO reflects a broader trend where companies prioritize sustainable growth and expansion over immediate public offerings, reshaping the landscape of digital health startups.